Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Asra Minerals

August 6, 2025

Massan Resource Drilling Confirms High Grade Continuity

September 30, 2025

Institutional Investment

October 1, 2025

How to Invest in Gold Royalty and Streaming...

November 20, 2025

Steve Barton: Gold, Silver, Uranium — Price Targets...

July 30, 2025

Humanoid Robotics: Key Trends to Watch and Investment...

December 2, 2025

US Reinstates Uranium as Critical Mineral, Boosting Domestic...

November 11, 2025

Altech – CERENERGY Project Secures German Grant Approval

January 6, 2026

Crypto Market Recap: Bitcoin Dips, Ripple Unveils Brokerage...

November 4, 2025

Green Technology Metals: Delivering the Next Lithium Hub...

September 18, 2025